1. Home
  2. LMFA vs MBRX Comparison

LMFA vs MBRX Comparison

Compare LMFA & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.26

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.24

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
MBRX
Founded
2008
2015
Country
United States
United States
Employees
19
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.1M
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
LMFA
MBRX
Price
$0.26
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$61.00
AVG Volume (30 Days)
390.8K
113.6K
Earning Date
03-27-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
28.08
N/A
EPS
N/A
N/A
Revenue
$10,999,648.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.25
52 Week High
$5.14
$7.98

Technical Indicators

Market Signals
Indicator
LMFA
MBRX
Relative Strength Index (RSI) 31.48 41.45
Support Level N/A $0.37
Resistance Level $0.44 $5.15
Average True Range (ATR) 0.04 0.14
MACD -0.01 0.10
Stochastic Oscillator 7.48 48.28

Price Performance

Historical Comparison
LMFA
MBRX

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: